Active Pharmaceutical Ingredients

The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products


AGC will boost its GMP-compliant pharma production

AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.

South Korean company acquires AMPAC Fine Chemicals

SK Holdings, the parent company of South Korea’s third-largest conglomerate SK Group, announced that it has acquired a 100 percent stake in AMPAC Fine Chemicals, a US-based contract manufacturer of APIs.

EMA reviews valsartan drugs after detecting an impurity

The European Medicines Agency (EMA) is reviewing medicines containing the active substance valsartan that is supplied by Zhejiang Huahai Pharmaceuticals, a Chinese pharma company.

Fermion launched a new API manufacturing facility in Finland

Fermion Oy, a privately held Finnish manufacturer of active pharmaceutical ingredients (APIs), has reached a significant milestone in its investment project by entering the commissioning phase of its new plant in Hanko (Finland).

Belarus developed the technology of obtaining povidone iodine

Belarus developed a technology for obtaining a pharmaceutical substance that can be used for manufacturing iodine-based medicines, announced Maria Sekach, Commercial Director of Belaseptika CJSC.

Former chemical weapon destruction plant will become a pharma facility

Moscow Endocrine Plant will acquire all sites of the former enterprise for destruction of chemical weapons in the Bryansk region in Q1 2019 aiming at establishing an affiliate for manufacturing active pharmaceutical substances.


Expert opinion